Focal cortical dysplasia

Pediatric Neurology

Volumn 49, Issue 2, 2013, Pages 79-87

  Gaitanis, John N ^a   Donahue, John ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CREATINE; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN; MULTIDRUG RESISTANCE PROTEIN 1; N ACETYLASPARTIC ACID; NESTIN; RAPAMYCIN;

ANTICONVULSANT THERAPY; CLINICAL FEATURE; COGNITIVE DEFECT; CORTICAL DYSPLASIA; DISEASE SEVERITY; DRUG EFFICACY; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTOGENESIS; FEVER; GRAY MATTER; HUMAN; NERVE CELL EXCITABILITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SEIZURE; WHITE MATTER;

HUMANS; MALFORMATIONS OF CORTICAL DEVELOPMENT;

EID: 84880307075     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2012.12.024     Document Type: Review

References (62)

1. P.B. Crino, and J. Eberwine Cellular and molecular basis of cerebral dysgenesis J Neurosci Res 50 1997 907 916
2. A.J. Barkovich Subcortical heterotopia: A distinct clinico-radiographic entity AJNR Am J Neuroradiol 17 1996 1315 1322
3. H. Yamanouchi, W. Zhang, V. Jay, and L.E. Becker Enhanced expression of microtubule-associated protein 2 in large neurons of cortical dysplasia Ann Neurol 39 1996 57 61
4. P.B. Crino, J. Trojanowski, and J. Eberwine Internexin, MAP1B, and nestin in cortical dysplasia as markers of developmental maturity Acta Neuropathol 93 1997 619 627
5. A.J. Barkovich, R.I., Kuzniecky, G.D. Jackson, R. Guerrini, and W.B. Dobyns Classification system for malformations of cortical development Neurology 57 2001 2168 2178
6. O. Robain Introduction to the pathology of cerebral cortical dysplasia R. Guerrini, F. Anderman, R. Camapicchi, R.J. Zifkin, P. Pfanner, Dysplasias of cerebral cortex and epilepsy 1996 Lippincott-Raven Philadelphia 1 9
7. L. Crome Infantile cerebral gliosis with giant nerve cells J Neurol Neurosurg Psychiatry 20 1957 117 124
8. H. Cravioto, and I. Feigin Localized cerebral gliosis with giant neurons histologically resembling tuberous sclerosis J Neuropathol Exp Neurol 19 1960 369 387
9. D.C. Taylor, M.A. Falconer, C.J. Bruton, and J.A. Corsellis Focal dysplasia of the cerebral cortex in epilepsy J Neurol Neurosurg Psychiatry 34 1971 369 387
10. P.S. Mischel, L.P. Nguyen, and H.V. Vinters Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system J Neuropathol Exp Neurol 54 1995 137 153
11. L. Tassi, N. Colombo, and R. Garbelli Focal cortical dysplasia: Neuropathological subtypes, EEG, neuroimaging and surgical outcome Brain 125 2002 1719 1732
12. A. Palmini, I. Najm, and G. Avanzini Terminology and classification of the cortical dysplasias Neurology 62 2004 S2 S8
13. I. Blümcke, M. Thom, and E. Aronica The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission Epilepsia 52 2011 158 174
14. I. Blümcke, and R. Spreafico An international concensus classification for focal cortical dysplasias Lancet Neurol 10 2011 26 27
15. K.A. Orlova, V. Tsai, and M. Baybis Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias J Neuropathol Exp Neurol 69 2010 850 863
16. P. Widdess-Walsh, C. Kellinghaus, and L. Jeha Electro-clinical and imaging characteristics of focal cortical dysplasia: Correlation with pathological subtypes Epilepsy Res 67 2005 25 33
17. F. Chassoux, B. Devaux, and E. Landre Stereo-electroencephalography in focal cortical dysplasia: A 3D approach to delineating the dysplastic cortex Brain 123 2000 1733 1751
18. P. Krsek, B. Maton, and B. Korman Different features of histopathological subtypes of pediatric focal cortical dysplasia Ann Neurol 63 2008 758 769
19. L. Tassi, R. Garbelli, and N. Colombo Type I focal cortical dysplasia: Surgical outcome is related to histopathology Epileptic Disord 12 2010 181 191
20. E. Wyllie, Y.G. Comair, P. Kotagal, J. Bulacio, W. Bingaman, and P. Ruggieri Seizure outcome after epilepsy surgery in children and adolescents Ann Neurol 44 1998 740 748
21. A. Gambardella, A. Palmini, and F. Andermann Usefulness of focal rhythmic discharges on scalp EEG of patients with focal cortical dysplasia and intractable epilepsy Electroencephalogr Clin Neurophysiol 98 1996 243 249
22. A. Palmini, A. Gambardella, and F. Andermann Intrinsic epilepto-genicity of human dysplastic cortex as suggested by corticography and surgical results Ann. Neurol 37 1995 476 487
23. K. Boonyapisit, I. Najm, and G. Klem Epileptogenicity of focal malformations due to abnormal cortical development: Direct electrocorticographic-histopathologic correlations Epilepsia 44 2003 69 76
24. P. Marusic, I.M. Najm, and Z. Ying Focal cortical dysplasias in eloquent cortex: Functional characteristics and correlation with MRI and histopathologic changes Epilepsia 43 2002 27 32
25. Y.H. Kim, H.C. Kang, and D.S. Kim Neuroimaging in identifying focal cortical dysplasia and prognostic factors in pediatric and adolescent epilepsy surgery Epilepsia 52 2011 722 727
26. A.J. Barkovich, R.I. Kuzniecky, A.W. Bollen, and P.E. Grant Focal transmantle dysplasia: A specific malformation of cortical development Neurology 49 1997 1148 1152
27. A.J. Barkovich, R.I. Kuzniecky, G.D. Jackson, R. Guerrini, and W.B. Dobyns A developmental and genetic classification for malformations of cortical development Neurology 65 2005 1873 1887
28. A.J. Barkovich, R. Guerrini, R.I. Kuzniecky, G.D. Jackson, and W.B. Dobyns A developmental and genetic classification for malformations of cortical development: update 2012 Brain 135 2012 1348 1369
29. I.L. Simone, F. Federico, and C. Tortorella Metabolic changes in neuronal migration disorders: Evaluation by combined MRI and proton MR spectroscopy Epilepsia 40 1999 872 879
30. B. Diehl, J. Tkach, and Z. Piao Diffusion tensor imaging in patients with focal epilepsy due to cortical dysplasia in the temporo-occipital region: Electro-clinico-pathological correlations Epilepsy Res 90 2010 178 187
31. F. Chassoux, S. Rodrigo, and F. Semah FDG-PET improves surgical outcome in negative MRI Taylor-type focal cortical dysplasias Neurology 75 2010 2168 2175
32. K. Goffin, W. Van Paesschen, and P. Dupont Anatomy-based reconstruction of FDG-PET images with implicit partial volume correction improves detection of hypometabolic regions in patients with epilepsy due to focal cortical dysplasia diagnosed on MRI Eur J Nucl Med Mol Imaging 37 2010 1148 1155
33. Butler T, Ichise M, Teich AF, et al. Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia. J Neuroimaging 2011 Jan 11 (Epub ahead of print).
34. H. Ak, B. Ay, and T. Tanriverdi Expression and cellular distribution of multidrug resistance-related proteins in patients with focal cortical dysplasia Seizure 16 2007 493 503
35. P. Iannetti, P. Parisi, A. Spalice, M. Ruggieri, and F. Zara Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy Epilepsy Res 85 2009 89 95
36. S.M. Sisodiya Surgery for malformations of cortical development causing epilepsy Brain 123 2000 1075 1091
37. A.A. Cohen-Gadol, K. Ozduman, R.A. Bronen, J.H. Kim, and D.D. Spencer Long-term outcome after epilepsy surgery for focal cortical dysplasia J Neurosurg 101 2004 55 65
38. J.C. Edwards, E. Wyllie, and P.M. Ruggeri Seizure outcome after surgery for epilepsy due to malformation of cortical development Neurology 55 2000 1110 1114
39. M. Tripathi, M.S. Singh, and M.V. Padma Surgical outcome of cortical dysplasias presenting with chronic intractable epilepsy: A 10-year experience Neurol India 56 2008 138 143
40. D.W. Kim, S.K. Lee, and K. Chu Predictors of surgical outcome and pathologic considerations in focal cortical dysplasia Neurology 72 2009 211 216
41. C. Skirrow, J.H. Cross, F. Cormack, W. Harkness, F. Vargha-Khadem, and T. Baldeweg Long-term intellectual outcome after temporal lobe surgery in childhood Neurology 76 2011 1330 1337
42. E. Roulet-Perez, V. Davidoff, and C. Mayor-Dubois Impact of severe epilepsy on development: Recovery potential after successful early epilepsy surgery Epilepsia 51 2010 1266 1276
43. O. Perier, and J. Achslogh Cure chirurgicale d'une epoilepsie focale dans un cas de sclerose tubereuse de Bourneville Acta Neurol Belg 65 1965 563 578
44. P. Perot, B. Weir, and T. Rasmussen Tuberous sclerosis. Surgical therapy for seizures Arch Neurol 15 1966 498 506
45. V. Narayanan Tuberous sclerosis complex: genetics to pathogenesis Pediatr Neurol 29 2003 404 409
46. C.J. Potter, H. Huang, and T. Xu Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size Cell 105 2001 357 368
47. X. Gao, Y. Zhang, and P. Arrazola Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling Nat Cell Biol 4 2002 699 704
48. D.R. Bolster, S.J. Crozier, S.R. Kimball, and L.S. Jefferson AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling J Biol Chem 277 2002 23977 23980
49. K. Inoki, Y. Li, T. Zhu, J. Wu, and K.L. Guan TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signaling Nat Cell Biol 4 2002 648 657
50. K. Inoki, M.N. Corradetti, and K.L. Guan Dysregulation of the TSC-mTOR pathway in human disease Nat Genet 37 2005 19 24
51. A.J. Becker, H. Urbach, and B. Scheffler Focal cortical dysplasia of Taylor's balloon cell type: Mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis Ann Neurol 52 2002 29 37
52. K. Boer, W.G. Spliet, P.C. van Rijen, F.E. Jansen, and E. Aronica Expression patterns of AMOG in developing human cortex and malformations of cortical development Epilepsy Re 91 2010 84 93
53. E. Erbayat-Altay, L.H. Zeng, L. Xu, D. Gutmann, and M. Wong The natural history and treatment of epilepsy in a murine model of tuberous sclerosis Epilepsia 48 2007 1470 1476
54. D.N. Franz, J. Leonard, and C. Tudor Rapamycin causes regression of astrocytomas in tuberous sclerosis complex Ann Neurol 59 2006 490 498
55. L.H. Zeng, L. Xu, D.H. Gutmann, and M. Wong Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex Ann Neurol 63 2008 444 453
56. D. Ehninger, S. Han, and C. Shiyansky Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis Nat Med 14 2008 843 848
57. D. Daoud, H.H. Scheld, E.J. Speckmann, and A. Gorji Rapamycin: Brain excitability studied in vitro Epilepsia 48 2007 834 836
58. S. Ruegg, M. Baybis, H. Juul, M. Dichter, and P.B. Crino Effects of rapamycin on gene expression, morphology, and electrophysiological properties of rat hippocampal neurons Epilepsy Res 77 2007 85 92
59. L. Meikle, K. Pollizzi, and A. Egnor Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: Effects on mTORC1 and Akt signaling lead to improved survival and function J Neurosci 28 2008 5422 5432
60. J. Muncy, I.J. Butler, and M.K. Koenig Rapamycin reduces seizure frequency in tuberous sclerosis complex J Child Neurol 24 2009 477
61. D.A. Krueger, M.M. Care, and K. Holland Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis N Engl J Med 363 2010 1801 1811
62. J.J. Bissler, F.X. McCormack, and L.R. Young Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis N Engl J Med 358 2008 140 151